• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines Pyridinylpiperazines

Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) (CAS No. 111960-11-3): A Comprehensive Overview

Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2), identified by its CAS number 111960-11-3, is a compound of significant interest in the field of pharmaceutical chemistry and drug development. This compound belongs to the piperazine class of heterocyclic amines, which are widely recognized for their diverse biological activities and potential therapeutic applications. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and a candidate for further pharmacological investigation.

The structural motif of Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) consists of a piperazine ring substituted with a 3-methyl-2-pyridinyl group. This unique arrangement confers specific electronic and steric properties that can influence its interaction with biological targets. The presence of the pyridine ring introduces additional hydrogen bonding capabilities and potential binding sites for enzymes and receptors, which are critical factors in drug design.

In recent years, there has been growing interest in developing novel compounds that incorporate piperazine derivatives due to their reported efficacy in various therapeutic areas. Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) has been investigated for its potential role in modulating neurological and cardiovascular functions. Preliminary studies suggest that this compound may exhibit properties relevant to the treatment of conditions such as depression, anxiety, and hypertension.

One of the most compelling aspects of Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) is its versatility as a building block in medicinal chemistry. The compound's structure allows for modifications at multiple positions, enabling chemists to explore a wide range of analogs with tailored biological activities. This flexibility has spurred numerous synthetic efforts aimed at optimizing pharmacokinetic profiles and enhancing therapeutic efficacy.

Recent advancements in computational chemistry have further accelerated the discovery process for compounds like Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2). Molecular docking studies have been conducted to predict potential interactions with target proteins, providing valuable insights into the compound's mechanism of action. These computational approaches have helped researchers prioritize candidates for experimental validation and have reduced the time required to identify promising drug candidates.

The synthesis of Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) involves multi-step organic reactions that require precise control over reaction conditions. Key steps include the formation of the piperazine core followed by functionalization with the 3-methyl-2-pyridinyl group. The final step involves conversion to the hydrochloride salt to improve solubility. Optimization of these synthetic routes is crucial for achieving high yields and purity levels necessary for pharmaceutical applications.

Evaluation of the pharmacological properties of Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) has revealed several interesting findings. In vitro studies have demonstrated its ability to interact with various receptors and enzymes, suggesting potential therapeutic benefits. Additionally, animal models have provided preliminary evidence of its efficacy in treating neurological disorders. These findings have laid the groundwork for further clinical investigations to assess its safety and effectiveness in human populations.

The development of novel pharmaceutical agents often involves rigorous testing to ensure both efficacy and safety. For compounds like Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2), this process includes comprehensive toxicological assessments to evaluate potential side effects. Understanding the compound's metabolic pathways and interactions with cytochrome P450 enzymes is essential for predicting its pharmacokinetic behavior and minimizing risks associated with drug administration.

The future prospects for Piperazine,1-(3-methyl-2-pyridinyl)-, hydrochloride (1:2) are promising as ongoing research continues to uncover new applications and refine synthetic methodologies. Collaborative efforts between academic institutions and pharmaceutical companies are likely to drive innovation in this area. As our understanding of biological systems grows more sophisticated, compounds like this one will play an increasingly important role in addressing complex diseases.

• 104395-86-0(1-(5-Methyl-2-pyridinyl)piperazine)
• 582325-38-0(Piperazine, 3-methyl-1-(3-methyl-2-pyridinyl)-, (3R)- (9CI))
• 348133-74-4(3-Methyl-2-piperazin-1-ylquinoline)
• 163613-81-8(Piperazine,1-(3,6-dimethyl-2-pyridinyl)-)
• 880362-05-0(1-(3-Methylpyridin-2-yl)-1,4-diazepane)
• 104396-10-3(1-(3-Methyl-2-pyridinyl)piperazine)
• 1185307-85-0(1-(5-methyl-2-pyridyl)piperazine;hydrochloride)
• 1187386-43-1(1-Methyl-4-(3-methylpyridin-2-yl)piperazine)
• 23845-99-0(1,2-Ethanediamine,N1,N1-diethyl-N2-hexyl-N2-(3-methyl-2-pyridinyl)-)
• 953748-71-5(1-[2-(4-methylpiperazin-1-yl)pyridin-3-yl]methanamine)